naturally acquired immunity

[키워드] accounted acquired immunity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults Affect age available doses can be used Characteristics Comorbidities coronavirus country COVID-19 COVID-19 vaccine cumulative cumulative incidence death disease distribution dose doses effective Efficacy estimate fatality FIVE greater groups immune Impact incidence individual individuals initial life Limited mathematical mathematical model Mortality naturally acquired immunity Older Older adults Perspective priority question raise reduce reducing required respiratory risk risk of death SARS-CoV-2 Science serological test Serological tests seronegative serostatus severe acute respiratory syndrome Coronavirus susceptibility the vaccine those with comorbidities those with comorbidity Transmission transmission rates vaccinate vaccination Vaccine vaccine efficacy Variation
[DOI] 10.1126/science.abe6959 PMC 바로가기 [Article Type] Research Article